NCT05346042View on ClinicalTrials.gov

Safe and Timely Cessation of Isolation of Patients With COVID-19 (The SCIP-COVID-19) Study

Active, not recruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

December 31, 2025

Conditions
COVID-19
Interventions
OTHER

duration infectiousness

is the probability and the duration of being infectious in hospitalized COVID-19 patients, consequently influencing the decision on cessation of isolation

Trial Locations (1)

3000 CA

Erasmus Medical Center, Rotterdam

All Listed Sponsors
collaborator

Maasstad Hospital

OTHER

collaborator

Medisch Spectrum Twente

OTHER

collaborator

Elisabeth-TweeSteden Ziekenhuis

OTHER

collaborator

Julius Center

OTHER

collaborator

HagaZiekenhuis

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Anne Voor in 't holt

OTHER